SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-17-005062
Filing Date
2017-08-14
Accepted
2017-08-14 17:30:10
Documents
3
Period of Report
2017-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_081417.htm 6-K 10687
2 EXHIBIT 99.1 exh_991.htm EX-99.1 24774
3 GRAPHIC image_001.jpg GRAPHIC 6904
  Complete submission text file 0001171843-17-005062.txt   46120
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 171031784
SIC: 2834 Pharmaceutical Preparations